USDA Approves Merck's Vaccine for Four Major Poultry Diseases

The US Department of Agriculture has approved Merck Animal Health's INNOVAX ND-IBD-ILT, a recombinant vaccine that protects against four major poultry diseases: Newcastle disease, infectious bursal disease, infectious laryngotracheitis, and Marek’s disease.

This is the first vaccine to offer protection against all four diseases in a single hatchery vaccination. The INNOVAX ND-IBD-ILT vaccine helps streamline vaccination programs and simplify flock health management by establishing broad immunity early on.

Poultry producers face increasing pressure to optimize flock health while managing labor and operational demands, making this vaccine a game-changer for the industry. 'Poultry producers and veterinarians need disease protection that is both comprehensive and practical,' said Charles Broussard, D.V.M., senior account manager for poultry sales at Merck Animal Health.